Biorational Product Sales Align with Record Apple Crop, Offset Increasing Shortage of Labor

  Biorational Product Sales Align with Record Apple Crop, Offset Increasing
  Shortage of Labor

Business Wire

LIBERTYVILLE, Ill. -- November 30, 2012

Valent BioSciences Corporation (VBC), a leader in biorational product
development for agriculture, public health, and forestry worldwide, announced
today it has achieved record sales for ReTain^® Plant Growth Regulator in line
with a record apple crop in Washington state, offsetting increasing challenges
among growers to secure farm labor.

Launched in 1996, ReTain is an advanced formulation of the biochemical
aminoethoxyvinylglycine (AVG). A natural compound produced through
fermentation, AVG inhibits the biosynthesis of ethylene in plants and has
become a mainstay in harvest management programs in the U.S. and other
prominent pome and stone fruit producing regions of the world.

Biorationals are products typically derived from biological origins that are
highly specific in their activity while providing economic, health, and/or
environmental benefits. Biorational products include microbial insecticides,
fungicides, and nematicides, as well as plant growth regulators used in
production agriculture and for managing plant growth, quality and stress in
crops.

“We applaud the efforts of the Washington apple industry for another record
crop and are proud of the role our products and support team have played in
achieving this milestone,” said Johan Pienaar, VBC’s global business manager
for the company’s plant growth regulator business unit. Pienaar indicates that
Washington is forecasting an apple crop in the range of 122 million packed
boxes for 2012, 10% higher than the record of 110 million boxes set last year.

By using ReTain, growers are able to delay ripening in desired blocks within
the orchard by precise amounts of time. In treating multiple blocks, growers
stagger their harvesting activities to align with the availability of their
labor resources while at the same time ensuring their fruit is picked at its
maximum level of quality.

Byron Phillips, the local sales representative for VBC’s sister company Valent
U.S.A. Corporation, said the ReTain experience has been a clear case of
growers gaining knowledge and experience with a technology that brings an
immediate impact on their bottom line.

“We’ve worked hand-in-hand with the Washington apple industry developing this
product for the last fifteen years,” Phillips said. “Over time, we’ve become
better at adjusting rates and timing based upon the variety, block, and the
goals of the particular grower. By working together and sharing information,
we continue to improve.”

Pienaar reports that additional products to support VBC’s extensive portfolio
of biorational sizing and thinning solutions are nearing commercialization.
The company is poised to launch its next offering in 2013.

About Valent BioSciences Corporation

About Valent BioSciences Corporation: Headquartered in Libertyville, IL,
Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company
and is the worldwide leader in the development, manufacturing and
commercialization of biorational products with sales in 95 countries around
the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For
additional information, visit the company’s website at
www.valentbiosciences.com.

About Valent U.S.A. Corporation

Valent, headquartered in Walnut Creek, Calif., develops and markets products
in the United States and Canada that protect agricultural crops, enhance crop
yields, improve food quality, beautify the environment and safeguard public
health. Valent products include a well-known line of quality herbicide,
insecticide, fungicide and plant growth regulator products for agricultural,
seed protection and professional use. It differentiates itself from its
competitors as a leader in marketing and sales of both biorational and
traditional chemical products. For additional information, visit the company’s
website at www.valent.com.

Contact:

Valent BioSciences Corporation
Media Contact:
Barbara Wendling, 847-968-4793
barbara.wendling@valentbiosciences.com
 
Press spacebar to pause and continue. Press esc to stop.